Stenotrophomonas maltophilia: A clinical perspective

Journal of Infectious Disease Pharmacotherapy

Volumn 2, Issue 1, 1996, Pages 1-14

  Benson, K K ^a   Raddatz, J K ^a   Rotschafer, J C ^a  

^a REGIONS HOSPITAL   (United States)

Author keywords

nosocomial; resistance; Stenotrophomonas maltophilia

Indexed keywords

1 CYCLOPROPYL 7 [3 [(ETHYLAMINO)METHYL] 1 PYRROLIDINYL] 6,8 DIFLUORO 1,4 DIHYDRO 4 OXO 3 QUINOLINECARBOXYLIC ACID; 7 (3 AMINO 1 PYRROLIDINYL) 1 CYCLOPROPYL 6,8 DIFLUORO 1,4 DIHYDRO 4 OXO 3 QUINOLINECARBOXYLIC ACID; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFCLIDIN; CEFOPERAZONE; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLAVULANIC ACID; CLINAFLOXACIN; FLEROXACIN; GENTAMICIN; MEROPENEM; MINOCYCLINE; OFLOXACIN; PENICILLIN DERIVATIVE; PIPERACILLIN; QUINOLONE DERIVATIVE; SPARFLOXACIN; TAZOBACTAM; TICARCILLIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; DRUG EFFECT; DRUG MECHANISM; HOSPITAL INFECTION; HUMAN; REVIEW; RISK FACTOR; STENOTROPHOMONAS MALTOPHILIA;

EID: 0029760717     PISSN: 10687777     EISSN: None     Source Type: Journal    
DOI: 10.1300/J100v02n01_01     Document Type: Review

References (0)